SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024067
Filing Date
2016-08-11
Accepted
2016-08-11 16:16:24
Documents
60
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20160630.htm 10-Q 1960146
2 EX-31.1 vktx-ex311_8.htm EX-31.1 19066
3 EX-31.2 vktx-ex312_7.htm EX-31.2 19137
4 EX-32.1 vktx-ex321_6.htm EX-32.1 12796
  Complete submission text file 0001564590-16-024067.txt   7920462

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vktx-20160630.xml EX-101.INS 1867178
6 XBRL TAXONOMY EXTENSION SCHEMA vktx-20160630.xsd EX-101.SCH 53466
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20160630_cal.xml EX-101.CAL 43327
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20160630_def.xml EX-101.DEF 204252
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20160630_lab.xml EX-101.LAB 401514
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20160630_pre.xml EX-101.PRE 343304
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 161824737
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences